ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Embryo Transfer Procedure Guided by Transvaginal Ultrasound Versus Abdominal Ultrasound in Oocytes Recipients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01137461
Recruitment Status : Completed
First Posted : June 4, 2010
Last Update Posted : April 14, 2011
Sponsor:
Information provided by:
Fundació Privada Eugin

Brief Summary:
The objective of this study is to evaluate the efficacy of embryo transfer procedure guided by transvaginal ultrasound versus abdominal ultrasound in recipients of oocytes as well as the advantages and disadvantages of the new technique.

Condition or disease Intervention/treatment Phase
Infertility Procedure: ultrasound-guided embryo transfer Phase 4

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 330 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evaluation of Efficacy of Embryo Transfer Procedure Guided by Transvaginal Ultrasound Versus Abdominal Ultrasound in Recipients of Oocytes. A Single-centre, Randomized Clinical Trial.
Study Start Date : June 2010
Actual Primary Completion Date : October 2010
Actual Study Completion Date : October 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
abdominal ultrasound
traditional technique
Procedure: ultrasound-guided embryo transfer
Embryo transfer in oocyte recipients
transvaginal ultrasound
new technique
Procedure: ultrasound-guided embryo transfer
Embryo transfer in oocyte recipients



Primary Outcome Measures :
  1. Clinical pregnancy rate [ Time Frame: 40 days after embryo transfer ]
    Evidence of gestational sac by transvaginal ultrasound



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Oocyte recipients.
  • Uterus without previously detected anomalies.
  • Patients able to understand the study requirements who want to participate during all its duration and that have signed the informed consent.

Exclusion Criteria:

  • Turner syndrome, Black race (significantly lower implantational rates)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01137461


Locations
Spain
Clinica EUGIN
Barcelona, Spain, 08029
Sponsors and Collaborators
Fundació Privada Eugin
Investigators
Principal Investigator: Daniel Bodri Clinica EUGIN

Additional Information:
Publications of Results:
Responsible Party: Dr. Daniel Bodri / Principal investigator, Clinica EUGIN
ClinicalTrials.gov Identifier: NCT01137461     History of Changes
Other Study ID Numbers: TATV
First Posted: June 4, 2010    Key Record Dates
Last Update Posted: April 14, 2011
Last Verified: April 2011

Keywords provided by Fundació Privada Eugin:
Female infertility with indication of oocyte reception

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female